Triage for COVID-19 Using Artificial Intelligence on Chest X-rays
Delft Imaging is specialised in tuberculosis (TB) screening and with its proven CAD4TB solution has screened over 6 million people in 40 countries. We optimised CAD4TB to triage COVID-19 suspects and are launching this solution free-of-charge.
CAD4COVID has been developed with the intention to support triaging in resource-constrained settings and high-prevalence areas. It has become available in the week of March 30th and its use will be free-of-charge.
COVID-19 is a global health crisis that will long be remembered and that has impacted the lives of millions of people around the world. Both low- and high-resource countries have been greatly impacted by this public health crisis. In response to this crisis, we want to support Ministries of Health and healthcare facilities around the world by leveraging our extensive experience in artificial intelligence and tuberculosis screening, with which we have already screened millions of people around the world.
The ingenuity behind CAD4COVID uses the same technical core as our proven software for tuberculosis detection, CAD4TB. CAD4TB is a significant part of the equation because CAD4COVID was built upon the same high-quality standard as CAD4TB, which is validated by over 40 academic publications and has contributed to screening 6 million people worldwide across 40 countries.
Today, we launch CAD4COVID, our free-of-charge solution that uses artificial intelligence on chest X-rays to triage COVID-19 suspects.
The diagnostic pathway for COVID-19
RT-PCR is the gold standard to confirm COVID-19. However, studies have shown that early stage of COVID-19 can be undetected by the lab test, where CT imaging is more likely to detect COVID-19 in early stages. CT imaging has shown to be a highly sensitive method to detect COVID-19. It is a reliable, practical and rapid method to detect and assess COVID-19. X-ray, although not as sensitive as CT, is also used among patients presenting COVID-19 symptoms especially since it uses less radiation, and is often cheaper, quicker and easier to use than CT and more available in resource-constrained settings. Further benefits of X-ray are that they can be portable and thus used at the patient’s bedside. The power of radiology in this crisis is highlighted as such: a positive diagnosis from radiology is definitive, even when a lab test is negative. Furthermore, radiology is an optimal method when it comes to assesing the progression of COVID-19 cases.
Click here for our FAQ about CAD4COVID
Why use artificial intelligence?
- Reduce the workload of the health workforce
- Enable quicker detection, therefore allowing for higher throughput
- Enhance diagnostic infrastructure in resource constrained settings
- Alleviate the burdens related to pathology tests.
- Quantify disease progress and recovery
 Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Case, Radiological Society of North America, February 26 2020; https://doi.org/10.1148/radiol.2020200642
Experts in screening across 40 countries
As companies that have built their foundation on improving diagnostics with innovative technology, we are committed to supporting the diagnosis of COVID-19 around the world. Thirona and Delft Imaging are active in 40 countries across the world. Delft Imaging focuses on developing countries and is stepping into the fight against COVID-19 to leverage its market access into Africa to ensure no community is left out.